Physician profile
Raul Valor
NPI 1982690939
$232,117.05
in general payments reported to CMS, 2019-2025
52 companies · $14K in 2025
The $14K reported for 2025 was more than what 94% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45K · 2020: $38K · 2021: $40K · 2022: $36K · 2023: $47K · 2024: $13K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $51K · Food and Beverage: $11K · Travel and Lodging: $6,720 · Consulting Fee: $5,550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $50,605.00 |
| Food and Beverage | $10,921.93 |
| Travel and Lodging | $6,719.73 |
| Consulting Fee | $5,550.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $105,214.70 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67,814.93 | 2019-2025 | Ofev, Jascayd, Spiriva |
| Astrazeneca Pharmaceuticals LP | $16,053.24 | 2019-2025 | Fasenra, Breztri, Airsupra |
| Sunovion Pharmaceuticals INC. | $14,777.05 | 2019-2020 | |
| Veran Medical Technologies, INC. | $5,550.51 | 2019-2020 | |
| Ethicon INC. | $5,321.66 | 2019-2025 | Monarch Platform |
| Pinnacle Biologics, INC | $4,743.53 | 2020-2023 | Photofrin |
| Medical Device Business Services, INC. | $2,868.96 | 2022-2025 | Monarch |
| Noah Medical Corporation | $2,463.92 | 2024 | Galaxy |
| Olympus Corporation of The Americas | $807.96 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $760.68 | 2019-2025 | Opsumit, Uptravi |
| Mallinckrodt Hospital Products INC. | $736.03 | 2021-2025 | Acthar |
| Genzyme Corporation | $617.28 | 2021-2025 | |
| Intuitive Surgical, INC. | $436.04 | 2023 | Da Vinci Surgical System |
| Insmed, INC. | $432.44 | 2021-2025 | Arikayce, Brinsupri |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $366.62 | 2019-2024 | (Ak6) Vest Therapy |
| Inspire Medical Systems, INC. | $337.16 | 2024-2025 | Inspire |
| Takeda Pharmaceuticals U.S.A., INC. | $287.05 | 2021-2024 | Glassia |
| Regeneron Healthcare Solutions, INC. | $248.85 | 2021-2025 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $247.15 | 2022-2024 | Opdivo |
| Verona Pharma, INC. | $242.15 | 2025 | Ohtuvayre |
| United Therapeutics Corporation | $195.80 | 2022-2025 | Tyvaso, Tyvaso |
| Mylan Specialty L.P. | $192.38 | 2019-2024 | Yupelri |
| Baxter Healthcare | $179.55 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Bayer Healthcare Pharmaceuticals INC. | $145.36 | 2021-2025 | |
| Mallinckrodt Enterprises LLC | $121.88 | 2019 | |
| Grifols USA, LLC | $120.06 | 2019 | |
| Advanced Respiratory, INC | $91.08 | 2020-2021 | |
| Fisher & Paykel Healthcare INC | $88.29 | 2023 | Fisher & Paykel Healthcare |
| Paratek Pharmaceuticals, INC. | $83.22 | 2023-2025 | Nuzyra |
| Merck Sharp & Dohme LLC | $82.81 | 2022-2025 | Winrevair |
| Inogen, INC. | $62.13 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Medtronic, INC. | $59.21 | 2022-2023 | Illumisite |
| Itamar Medical INC | $46.56 | 2025 | Watchpatone |
| Pentax of America, INC. | $38.86 | 2020 | |
| Amgen INC. | $37.22 | 2022 | |
| Vifor Pharma, INC. | $27.95 | 2024 | Veltassa |
| Pulmonx Corporation | $27.19 | 2023 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Abbvie INC. | $26.69 | 2022 | |
| Lilly USA, LLC | $22.59 | 2025 | Zepbound |
| Viatris Specialty LLC | $18.55 | 2025 | Yupelri |
| Liquidia Technologies, INC. | $18.44 | 2025 | Yutrepia |
| Novartis Pharmaceuticals Corporation | $18.41 | 2021 | |
| Nabriva Therapeutics, Plc | $16.91 | 2021 | |
| Genentech USA, INC. | $16.55 | 2021 | |
| Hikma Pharmaceuticals USA | $16.10 | 2024 | Ryaltris |
| Resmed Corp | $14.15 | 2019 | |
| Cmp Pharma, INC. | $12.86 | 2023 | Tadliq |
| Janssen Pharmaceuticals, INC | $8.34 | 2021 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raul Valor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.